Log in

LAB Labiana Health SA BME · Spain

Labiana Health SA (LAB) news LAB settlement news

Latest Labiana Health SA news

  1. Listings

    Standard BioTools gets Nasdaq minimum bid price notice, has until January 19, 2027

    Nasdaq told Standard BioTools on July 22, 2026 that its shares closed below $1.00 for 30 days. The company has until January 19, 2027 to regain compliance, and its own filing says it cannot be sure it will.

Questions about Labiana Health SA

Has Labiana Health SA settled a lawsuit?

Our latest story on this, dated Oct 21, 2026: "SomaLogic stockholder suit heads to 2027 trial without Standard BioTools; Palamedrix claim settled". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of Labiana Health SA?

Labiana Health SA trades under the ticker LAB on BME.

Where is Labiana Health SA listed?

Labiana Health SA is listed on BME.

Which country or territory is Labiana Health SA listed under?

Our directory records Labiana Health SA under Spain.

What does Labiana Health SA do?

Our directory classifies Labiana Health SA as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Labiana Health SA?

The ISIN recorded for Labiana Health SA is ES0105638003.

Does aibio.space cover Labiana Health SA?

aibio.space lists Labiana Health SA among 2,820 public biotech companies and publishes its news here as stories appear.

What is the latest Labiana Health SA (LAB) stock news?

Our latest story on Labiana Health SA, dated Oct 21, 2026: "SomaLogic stockholder suit heads to 2027 trial without Standard BioTools; Palamedrix claim settled". A Delaware suit naming Casdin Capital and SomaLogic directors is set for a March 2027 bench trial. SRS had claimed up to $17.5 million in Palamedrix milestones; that matter is resolved and the company paid Illumina $7.5 million on its indemnity. Source.

Is Labiana Health SA at risk of delisting?

Our latest listing story, dated Jul 24, 2026: "Standard BioTools gets Nasdaq minimum bid price notice, has until January 19, 2027". Nasdaq told Standard BioTools on July 22, 2026 that its shares closed below $1.00 for 30 days. The company has until January 19, 2027 to regain compliance, and its own filing says it cannot be sure it will. Source.

Which companies are similar to Labiana Health SA?

Companies in our directory listed in the same country and business area as Labiana Health SA: Almirall SA, Grifols, Laboratorios Farmaceuticos Rovi, Faes Farma, LABORATORIO REIG JOFRE, Oryzon Genomics SA.

How can I follow Labiana Health SA (LAB) news?

Press Follow on this page to add Labiana Health SA to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming Labiana Health SA so far, in Legal, Listings.

Investor discussion: Labiana Health SA

Members talk about Labiana Health SA (LAB). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BME:LAB on TradingView.

Listing details

Labiana Health SA is a public biotech or pharmaceutical company listed on BME under the ticker LAB, recorded under Spain. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Labiana Health SA
Ticker
LAB
Listing
BME
Country or territory
Spain
Business scope
Pharmaceuticals: Major
ISIN
ES0105638003
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.